Sunday, October 18, 2020 4:07:50 PM
Just my humble opinion, welcome to be corrected.
Revive REPURPOSED Rimatil (Bucilimine) for COVID 19. Once successful,
Revive may have worldwide Rights except East Asia (Santen company).
Yes, Santen is BIG, they may even manufacture and distribute it too
(just guessing).
No worries folks......very soon - in few weeks, SP will be HIGH ! Very High
Best Wishes
Revive REPURPOSED Rimatil (Bucilimine) for COVID 19. Once successful,
Revive may have worldwide Rights except East Asia (Santen company).
Yes, Santen is BIG, they may even manufacture and distribute it too
(just guessing).
No worries folks......very soon - in few weeks, SP will be HIGH ! Very High
Best Wishes
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
